🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Cathie Wood's ARK sells Teladoc and Zoom, buys Roku and 10x Genomics stock

EditorLina Guerrero
Published 06/26/2024, 08:04 PM
TDOC
-
ROKU
-
ZM
-
TXG
-

Cathie Wood's ARK ETFs have published their daily trades for Wednesday, June 26th, 2024, revealing a mix of significant buys and sells across the technology and biotech sectors. Leading the sales was a substantial move away from TELADOC HEALTH INC (NYSE:TDOC), with a total of 913,759 shares sold, valued at approximately $8.9 million. This continues a selling trend for TDOC, as ARK has been reducing its position over the past week.

In the realm of communication technology, ARK also reduced its holdings in ZOOM VIDEO COMMUNICATIONS INC (NASDAQ:ZM) by 52,072 shares, amounting to a sale of around $3 million. This follows a series of sales in ZM stock over the recent trading days, indicating a possible strategic shift by the fund.

On the buying side, ARK showed a strong vote of confidence in ROKU INC (NASDAQ:ROKU), purchasing 127,540 shares with a total dollar value of nearly $7 million. This buy is part of a growing trend, as ARK has consistently increased its ROKU holdings throughout the previous week.

Another notable buy was in 10X GENOMICS INC (NASDAQ:TXG), where ARK acquired 399,912 shares, translating to an investment of over $7.8 million. This move reinforces ARK's bullish stance on the genomic space, as evidenced by their repeated purchases of TXG shares in recent days.

Among other significant trades, ARK bought 88,735 shares of INTELLIA THERAPEUTICS INC (NASDAQ:NTLA) for roughly $2.1 million and increased its stake in ADAPTIVE BIOTECHNOLOGIES CORP (NASDAQ:ADPT) by 90,295 shares, valued at over $300,000.

Smaller transactions included a buy of 78,693 shares of ABSCI CORP (NASDAQ:ABSI) and a sale of 3,278 shares of COINBASE GLOBAL INC (NASDAQ:COIN), with the latter amounting to approximately $726,000. Additionally, ARK sold off a minor position of 400 shares in VELO3D INC (NYSE:VLD) and 3,490 shares of EXACT SCIENCES CORP (NASDAQ:EXAS).

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.